Senco Gold Shines Bright
- 09th April 2025
Aaj Ka Bazaar
US markets slipped into the red on Tuesday, despite early-session gains, as investor sentiment turned sour following a key trade policy update. The U.S. shared plans to impose a 104% duty on select imports from China in the near term, dampening hopes of a resolution to ongoing trade tensions. This development weighed heavily on equities, marking the fourth consecutive session of losses. The S&P 500 is now down nearly 19% from its February high, approaching the 20% threshold typically used to define a bear market. The negative sentiment spilled over into Asian markets, with major indices trading lower in early hours. Japan’s Nikkei and Hong Kong’s Hang Seng both declined by over 2%, reflecting rising concerns about global growth and the escalating U.S.–China trade standoff. In Japan, fading hopes of tariff relief have further fueled economic uncertainty, while in Hong Kong, markets are reeling from the intensifying trade conflict, with neither side showing signs of backing down. Back home, Indian markets are poised for a weak start, mirroring global trends. Early indications from GIFT Nifty suggest a subdued opening, as investor sentiment remains under pressure amid persistent geopolitical and economic headwinds. Meanwhile, crude oil prices continue to slide, which could pose headwinds for OMCs in today’s session.
Markets Around Us
BSE Sensex – 73,891.75 (-0.45%)
Nifty 50 – 22,426.90 (-0.48%)
Bank Nifty – 50,377.10 (-0.27%)
Dow Jones – 37,112.38 (-1.42%)
Nasdaq – 15,267.91 (-2.15%)
FTSE – 7,910.53 (2.64%)
Nikkei 225 – 31,761.31 (-3.76%)
Hang Seng – 19,817.50 (-1.56%)
Sector: Gems, Jewellery & Watches
Senco Gold Achieves Record Q4 Revenue
On April 9, Senco Gold shares hit the 5% upper circuit at ₹317 after the company posted its highest-ever Q4 revenue of over ₹1,300 crore, up 19.1% year-on-year. For the full financial year, revenue crossed ₹6,200 crore, showing strong 19.4% growth in retail. This performance was driven by high wedding and festive demand, leading to more store visits and higher customer billing. Same-store sales grew 18.4% for the quarter. Tier 3 and Tier 4 towns saw faster growth than metros, while non-East India markets also grew 23%. Diamond jewellery sales jumped 39%, and the studded jewellery ratio improved slightly. Gold coins and bullion made up less than 4% of total sales. The company opened 15 new showrooms in FY25, including 4 in Q4, expanding its network to 175 stores across India and Dubai. Despite strong Q4 numbers, the stock is still down 46% in 2025, while Nifty 50 has slipped just 5%.
Why it Matters:
This update matters because Senco Gold’s record-breaking revenue highlights strong consumer demand, particularly from Tier 3 and Tier 4 towns, indicating a shift in market momentum. The company’s focus on expanding its retail footprint and growth in high-margin diamond jewellery suggests solid long-term potential. Despite these strong fundamentals, the stock has declined over 46% this year, making it an undervalued opportunity that traders and investors may want to watch closely.
NIFTY 50 GAINERS
POWER GRID CORP – 294.30 (1.87%)
NESTLE – 2306.45 (1.36%)
HUL– 2310.45 (0.93%)
NIFTY 50 LOSERS
WIPRO – 238.95 (-3.36%)
TECH MAHINDRA – 1276.15 (-2.91%)
DR REDDY LABS – 1077.80 (-2.72%)
Sector : Pharma
Trump Tariffs Hit Pharma Stocks Hard
Indian pharma stocks, including Sun Pharma, Gland Pharma, Lupin, and others, fell sharply on Wednesday after former U.S. President Donald Trump announced plans to impose major tariffs on pharmaceutical imports. Gland Pharma dropped nearly 6%, Aurobindo Pharma fell close to 5%, and Biocon slipped over 4%, while many other pharma stocks also declined 2-3%. As a result, the Nifty Pharma index was down by 2.64%. Trump stated that the new tariffs are aimed at encouraging drug companies to bring their operations back to the U.S. This announcement is part of a larger trade strategy where the U.S. will apply a minimum 10% tariff on almost all trading partners, with higher duties for countries running trade surpluses with the U.S. A new round of these tariffs has already begun, with the broader plan branded as “Liberation Day.” The move is expected to impact global pharmaceutical supply chains and investor sentiment in the sector.
Why it Matters:
This development matters as U.S. tariffs on pharma imports could significantly impact Indian pharmaceutical exports and revenues. It raises concerns over global supply chain disruptions, especially for companies dependent on the U.S. market. The sharp drop in pharma stocks reflects investor anxiety about future trade and regulatory challenges.
Around the World
Asian markets dropped sharply on Wednesday after a short-lived recovery, as U.S. President Donald Trump raised tariffs on Chinese goods to a steep 104%, intensifying global trade tensions. Japan’s Nikkei fell 3%, Hong Kong’s Hang Seng dropped over 2%, and South Korea’s KOSPI slipped 1%, now nearing bear market territory with a 20% fall from its peak. While Chinese markets stayed mostly steady due to government support from state-backed funds, global investor sentiment remained weak. The Shanghai Composite edged down 0.2%, and the CSI 300 was flat. Australia, Singapore, and India also saw declines, with futures on India’s Nifty 50 down 0.4% ahead of the RBI’s expected rate cut. U.S. markets also saw heavy losses overnight, with the S&P 500 falling below 5,000 for the first time in a year. The deepening U.S.-China trade war is now a key worry for markets, triggering fears of a broader slowdown in global growth.
Option Traders Corner
Max Pain
Nifty 50 – 22500
Bank Nifty – 51000
Nifty 50 – 22501 (Pivot)
Support – 22,305, 22,074, 21,879
Resistance – 22,731, 22,927, 23,158
Bank Nifty – 50445 (Pivot)
Support – 50,096, 49,682, 49,333
Resistance – 50,859, 51,208, 51,622
Have you checked our latest YouTube Video
Did you know?
India’s Retail Investor Surge: Market Participation Hits Record Highs in 2024
India’s stock market has seen a 36% rise in retail participation, with over 50 million investors active by 2024. This surge is driven by increased financial literacy, digital trading platforms, and government initiatives. Systematic Investment Plans (SIPs) have also gained popularity, with monthly contributions hitting ₹14,000 crore in early 2025. These trends reflect growing confidence in India’s equity markets.
